Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban in Heparin-Induced Thrombocytopenia
NCT00198588Phase 3Completed
- Sponsor
- Ministry of Health, Labour and Welfare
- Start
- Jun 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of argatroban in heparin-induced thrombocytopenia (HIT), Heparin-induced thrombocytopenia with thrombosis syndrome (HITTS), sponsored by Ministry of Health, Labour and Welfare. Started Jun 2005; status: completed.
02
Drugs
argatroban
03
Conditions
heparin-induced thrombocytopenia (HIT)Heparin-induced thrombocytopenia with thrombosis syndrome (HITTS)
Beyond the preview
Go deeper on NCT00198588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00198588.